- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: eudract_number:2015-000575-27.
Displaying page 1 of 1.
EudraCT Number: 2015-000575-27 | Sponsor Protocol Number: MK-3475-091-05 | Start Date*: 2015-09-17 | |||||||||||
Sponsor Name:Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: A randomized, phase 3 trial with anti-PD-1 monoclonal antibody pembrolizumab (MK-3475) versus placebo for patients with early stage NSCLC after resection and completion of standard adjuvant therapy... | |||||||||||||
Medical condition: Stage IB (T ≥ 4 cm), II and IIIA NSCLC | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Ongoing) SI (Ongoing) GB (GB - no longer in EU/EEA) DE (Ongoing) ES (Ongoing) EE (Ongoing) HU (Ongoing) PT (Ongoing) BE (Ongoing) AT (Ongoing) NL (Ongoing) DK (Ongoing) GR (Ongoing) LV (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.